The Biden-Harris Administration has
brought two new over-the-counter, at-home COVID-19 tests to the U.S.
market. The tests, one manufactured by SD
Biosensor and distributed by Roche and the other manufactured by Siemens
, have received emergency use authorization (EUA) by the Food and
Drug Administration (FDA) after being evaluated through the
Administration’s new accelerated pathway to support FDA review of tests
with potential for large-scale manufacturing that the Department of
Health and Human Services (HHS) announced
just two months ago. Read full news release
|
No comments:
Post a Comment